{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,27]],"date-time":"2026-08-27T01:09:14Z","timestamp":1787792954574,"version":"build-2784847793"},"reference-count":29,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2019,1,5]],"date-time":"2019-01-05T00:00:00Z","timestamp":1546646400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2019,1,5]],"date-time":"2019-01-05T00:00:00Z","timestamp":1546646400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000774","name":"Defense Threat Reduction Agency","doi-asserted-by":"publisher","award":["HDTRA1-14-C-0115"],"award-info":[{"award-number":["HDTRA1-14-C-0115"]}],"id":[{"id":"10.13039\/100000774","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Virol J"],"published-print":{"date-parts":[[2019,12]]},"DOI":"10.1186\/s12985-018-1103-7","type":"journal-article","created":{"date-parts":[[2019,1,5]],"date-time":"2019-01-05T13:26:10Z","timestamp":1546694770000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":26,"title":["Aerosol infection of Balb\/c mice with eastern equine encephalitis virus; susceptibility and lethality"],"prefix":"10.1186","volume":"16","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7241-3443","authenticated-orcid":false,"given":"Amanda L.","family":"Phelps","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lyn M.","family":"O\u2019Brien","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lin S.","family":"Eastaugh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carwyn","family":"Davies","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark S.","family":"Lever","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jane","family":"Ennis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Larry","family":"Zeitlin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alejandro","family":"Nunez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David O.","family":"Ulaeto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,1,5]]},"reference":[{"key":"1103_CR1","unstructured":"CDC, (2018) \n                    https:\/\/www.cdc.gov\/easternequineencephalitis\/tech\/epi.html\n                    \n                  . Accessed 21 Nov 2018."},{"issue":"5","key":"1103_CR2","doi-asserted-by":"publisher","first-page":"790","DOI":"10.1177\/0300985810372508","volume":"47","author":"KE Steele","year":"2010","unstructured":"Steele KE, Twenhafel NA. Review paper: pathology of animal models of alphavirus encephalitis. Vet Pathol. 2010;47(5):790\u2013805.","journal-title":"Vet Pathol"},{"key":"1103_CR3","doi-asserted-by":"publisher","first-page":"959","DOI":"10.3389\/fmicb.2016.00959","volume":"7","author":"SE Ronca","year":"2016","unstructured":"Ronca SE, Dineley KT, Paessler S. Neurological sequelae resulting from encephalitic alphavirus infection. Front Microbiol. 2016;7:959.","journal-title":"Front Microbiol"},{"key":"1103_CR4","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1007\/BF01320552","volume":"47","author":"A Brown","year":"1975","unstructured":"Brown A, Officer JE. An attenuated variant of Eastern equine encephalitis virus: biological properties and protection induced in mice. Arch Virol. 1975;47:123\u201338.","journal-title":"Arch Virol"},{"key":"1103_CR5","first-page":"181","volume-title":"Biodefense: research methodology and animal models","author":"WD Pratt","year":"2006","unstructured":"Pratt WD, Hart ML, Reed DS, Steele KE. Alphaviruses. In: Swearengen JR, editor. Biodefense: research methodology and animal models. Boca Raton: Taylor & Francis; 2006. p. 181\u2013206."},{"key":"1103_CR6","doi-asserted-by":"publisher","first-page":"163","DOI":"10.3390\/v9070163","volume":"9","author":"AL Phelps","year":"2017","unstructured":"Phelps AL, O\u2019Brien LM, Eastaugh LS, Davies C, Lever MS, Ennis J, Zeitlin L, Nunez A, Ulaeto DO. Susceptibility and lethality of Western equine encephalitis virus in Balb\/c mice when infected by the aerosol route. Viruses. 2017;9:163.","journal-title":"Viruses"},{"key":"1103_CR7","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1186\/s12985-015-0386-1","volume":"12","author":"SP Honnold","year":"2015","unstructured":"Honnold SP, Mossel EC, Bakken RR, Fisher D, Lind CM, Cohen JW, Eccleston LT, Spurgers KB, Erwin-Cohen R, Bradfute SB, Maheshwari RK, Glass PJ. Eastern equine encephalitis virus in mice I: clinical course and outcome are dependent on route of exposure. Virol J. 2015;12:152.","journal-title":"Virol J"},{"key":"1103_CR8","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1186\/s12985-015-0385-2","volume":"12","author":"SP Honnold","year":"2015","unstructured":"Honnold SP, Mossel EC, Bakken RR, Lind CM, Cohen JW, Eccleston LT, Spurgers KB, Erwin-Cohen R, Glass PJ, Maheshwari RK. Eastern equine encephalitis virus in mice II: pathogenesis is dependent on route of exposure. Virol J. 2015;12:154.","journal-title":"Virol J"},{"key":"1103_CR9","doi-asserted-by":"publisher","first-page":"1283","DOI":"10.1126\/science.158.3806.1283","volume":"158","author":"RP Hanson","year":"1967","unstructured":"Hanson RP, Sulkin SE, Buescher EL, McD Hammon W, McKinney RW, Work TH. Arbovirus infections of laboratory workers. Science. 1967;158:1283\u20136.","journal-title":"Science"},{"issue":"18","key":"1103_CR10","doi-asserted-by":"publisher","first-page":"9035","DOI":"10.1128\/JVI.00674-08","volume":"82","author":"AP Adams","year":"2008","unstructured":"Adams AP, Aronson JF, Tardif SD, Patterson JL, Brasky KM, Geiger R, de la Garza M, Carrion R Jr, Weaver SC. Common marmosets (Callithrix jacchus) as a nonhuman primate model to assess the virulence of eastern equine encephalitis virus strains. J Virol. 2008;82(18):9035\u201342.","journal-title":"J Virol"},{"key":"1103_CR11","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1016\/0021-9975(69)90034-6","volume":"79","author":"N Nathanson","year":"1969","unstructured":"Nathanson N, Stolley PD, Boolukos PJ. Eastern equine encephalitis. Distribution of central nervous system lesions in mand and rhesus monkey. J Comp Pathol. 1969;79:109\u201315.","journal-title":"J Comp Pathol"},{"issue":"1","key":"1103_CR12","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1186\/s12985-017-0687-7","volume":"14","author":"AI Porter","year":"2017","unstructured":"Porter AI, Erwin-Cohen RA, Twenhafel N, Chance T, Yee SB, Kern SJ, Norwood D, Hartman LJ, Parker MD, Glass PJ, DaSilva L. Characterization and pathogenesis of aerosolized eastern equine encephalitis in the common marmoset (Callithrix jacchus). Virol J. 2017;14(1):25.","journal-title":"Virol J"},{"key":"1103_CR13","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1086\/519391","volume":"196","author":"DS Reed","year":"2007","unstructured":"Reed DS, Lackemeyer MG, Garza NL, Norris S, Gamble S, Sullivan LJ, Lind CM, Raymond JL. Severe encephalitis in cynomolgus macaques exposed to aerosolized eastern equine encephalitis virus. J Infect Dis. 2007;196:441\u201350.","journal-title":"J Infect Dis"},{"key":"1103_CR14","unstructured":"US Department of Health and Human Services Food and Drug Administration (DHHS FDA), Center for Drug Evaluation and Research (CDER), Center for Biologics Evaluation and Research (CBER). Product Development under the Animal Rule. Guidance for industry. 2015. \n                    https:\/\/www.fda.gov\/EmergencyPreparedness\/Counterterrorism\/MedicalCountermeasures\/MCMRegulatoryScience\/ucm391665.htm\n                    \n                  . Accessed 21 Nov 2018."},{"key":"1103_CR15","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1152\/ajplegacy.1947.150.1.70","volume":"150","author":"AC Guyton","year":"1947","unstructured":"Guyton AC. Measurement of the respiratory volumes of laboratory animals. Am J Phys. 1947;150:70\u20137.","journal-title":"Am J Phys"},{"issue":"3","key":"1103_CR16","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1093\/oxfordjournals.aje.a118408","volume":"27","author":"Reed and Muench","year":"1938","unstructured":"Reed and Muench. A simple method of estimating fifty percent endpoints. Am J Epid. 1938;27(3):493\u20137.","journal-title":"Am J Epid"},{"key":"1103_CR17","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1186\/1743-422X-6-170","volume":"6","author":"CJ Roy","year":"2009","unstructured":"Roy CJ, Reed DS, Wilhelmsen CL, Hartings J, Norris S, Steele KE. Pathogenesis of aerosolized Eastern Equine Encephalitis virus infection in guinea pigs. Virol J. 2009;6:170.","journal-title":"Virol J"},{"key":"1103_CR18","doi-asserted-by":"crossref","unstructured":"Gardner CL, Sun C, Luke T, Raviprakash K, Wu H, Jiao JA, Sullivan E, Reed DS, Ryman KD, Klimstra WB. Antibody Preparations from Human Transchromosomic Cows Exhibit Prophylactic and Therapeutic Efficacy against Venezuelan Equine Encephalitis Virus. J Virol. 2017;91(14):e00226\u201317.","DOI":"10.1128\/JVI.00226-17"},{"issue":"2","key":"1103_CR19","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1016\/j.virol.2011.03.016","volume":"414","author":"AR Hunt","year":"2011","unstructured":"Hunt AR, Bowen RA, Frederickson S, Maruyama T, Roehrig JT, Blair CD. Treatment of mice with human monoclonal antibody 24h after lethal aerosol challenge with virulent Venezuelan equine encephalitis virus prevents disease but not infection. Virology. 2011;414(2):146\u201352.","journal-title":"Virology"},{"issue":"2","key":"1103_CR20","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1016\/j.virol.2012.01.038","volume":"426","author":"LM O'Brien","year":"2012","unstructured":"O'Brien LM, Goodchild SA, Phillpotts RJ, Perkins SD. A humanised murine monoclonal antibody protects mice from Venezuelan equine encephalitis virus, Everglades virus and Mucambo virus when administered up to 48 h after airborne challenge. Virology. 2012;426(2):100\u20135.","journal-title":"Virology"},{"issue":"11\u201312","key":"1103_CR21","doi-asserted-by":"publisher","first-page":"1497","DOI":"10.1016\/S0264-410X(01)00505-9","volume":"20","author":"RJ Phillpotts","year":"2002","unstructured":"Phillpotts RJ, Jones LD, Howard SC. Monoclonal antibody protects mice against infection and disease when given either before or up to 24 h after airborne challenge with virulent Venezuelan equine encephalitis virus. Vaccine. 2002;20(11\u201312):1497\u2013504.","journal-title":"Vaccine"},{"issue":"5","key":"1103_CR22","doi-asserted-by":"publisher","first-page":"e37242","DOI":"10.1371\/journal.pone.0037242","volume":"7","author":"T R\u00fclker","year":"2012","unstructured":"R\u00fclker T, Vo\u00df L, Thullier P, O\u2019 Brien LM, Pelat T, Perkins SD, Langermann C, Schirrmann T, D\u00fcbel S, Marschall HJ, Hust M, H\u00fclseweh B. Isolation and characterisation of a human-like antibody fragment (scFv) that inactivates VEEV in vitro and in vivo. PLoS One. 2012;7(5):e37242.","journal-title":"PLoS One"},{"key":"1103_CR23","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1016\/j.antiviral.2018.07.005","volume":"157","author":"L Lundberg","year":"2018","unstructured":"Lundberg L, Brahms A, Hooper I, Carey B, Lin SC, Dahal B, Narayanan A, Kehn-Hall K. Repurposed FDA-Approved drug sorafenib reduces replication of Venezuelan equine encephalitis virus and other alphaviruses. Antivir Res. 2018;157:57\u201367.","journal-title":"Antivir Res"},{"key":"1103_CR24","doi-asserted-by":"publisher","first-page":"8521060","DOI":"10.1155\/2018\/8521060","volume":"2018","author":"LC Dupuy","year":"2018","unstructured":"Dupuy LC, Richards MJ, Livingston BD, Hannaman D, Schmaljohn CS. A Multiagent Alphavirus DNA Vaccine Delivered by Intramuscular Electroporation Elicits Robust and Durable Virus-Specific Immune Responses in Mice and Rabbits and Completely Protects Mice against Lethal Venezuelan, Western, and Eastern Equine Encephalitis Virus Aerosol Challenges. J Immunol Res. 2018;2018:8521060.","journal-title":"J Immunol Res"},{"issue":"34","key":"1103_CR25","doi-asserted-by":"publisher","first-page":"5194","DOI":"10.1016\/j.vaccine.2018.06.064","volume":"36","author":"WG Hu","year":"2018","unstructured":"Hu WG, Steigerwald R, Kalla M, Volkmann A, Noll D, Nagata LP. Protective efficacy of monovalent and trivalent recombinant MVA-based vaccines against three encephalitic alphaviruses. Vaccine. 2018;36(34):5194\u2013203.","journal-title":"Vaccine"},{"issue":"20","key":"1103_CR26","doi-asserted-by":"publisher","first-page":"12077","DOI":"10.1128\/JVI.01406-14","volume":"88","author":"DS Reed","year":"2014","unstructured":"Reed DS, Glass PJ, Bakken RR, Barth JF, Lind CM, da Silva L, Hart MK, Rayner J, Alterson K, Custer M, Dudek J, Owens G, Kamrud KI, Parker MD, Smith J. Combined alphavirus replicon particle vaccine induces durable and cross-protective immune responses against equine encephalitis viruses. J Virol. 2014;88(20):12077\u201386.","journal-title":"J Virol"},{"issue":"5","key":"1103_CR27","doi-asserted-by":"publisher","first-page":"e0003797","DOI":"10.1371\/journal.pntd.0003797","volume":"9","author":"SL Rossi","year":"2015","unstructured":"Rossi SL, Russell-Lodrigue KE, Killeen SZ, Wang E, Leal G, Bergren NA, Vinet-Oliphant H, Weaver SC, Roy CJ. IRES-Containing VEEV Vaccine Protects Cynomolgus Macaques from IE Venezuelan Equine Encephalitis Virus Aerosol Challenge. PLoS Negl Trop Dis. 2015;9(5):e0003797 Erratum in: \n                    PLoS Negl Trop Dis. 2015 Jun;9(6):e0003912\n                    \n                  .","journal-title":"PLoS Negl Trop Dis"},{"issue":"31","key":"1103_CR28","doi-asserted-by":"publisher","first-page":"3607","DOI":"10.1016\/j.vaccine.2016.04.077","volume":"34","author":"D Hannaman","year":"2016","unstructured":"Hannaman D, Dupuy LC, Ellefsen B, Schmaljohn CS. A Phase 1 clinical trial of a DNA vaccine for Venezuelan equine encephalitis delivered by intramuscular or intradermal electroporation. Vaccine. 2016;34(31):3607\u201312.","journal-title":"Vaccine"},{"key":"1103_CR29","unstructured":"Parker M, Fine D, Glass P, Terpening S, Mallory RM, Helbers S. Phase I Clinical Trial of V3526, Virological and Serological Analyses. 2008. Conference Paper: The American journal of tropical medicine and hygiene, 57th annual meeting. Conference: 5. Volume 79."}],"container-title":["Virology Journal"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12985-018-1103-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12985-018-1103-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12985-018-1103-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,15]],"date-time":"2020-05-15T10:10:46Z","timestamp":1589537446000},"score":1,"resource":{"primary":{"URL":"https:\/\/virologyj.biomedcentral.com\/articles\/10.1186\/s12985-018-1103-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,1,5]]},"references-count":29,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019,12]]}},"alternative-id":["1103"],"URL":"https:\/\/doi.org\/10.1186\/s12985-018-1103-7","relation":{},"ISSN":["1743-422X"],"issn-type":[{"value":"1743-422X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,1,5]]},"assertion":[{"value":"13 August 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 December 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 January 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"All studies with experimental animals were performed in accordance with the UK Scientific Procedures (Animals) Act 1986 and the UK Codes of Practice for the Housing and Care of Animals Used in Scientific Procedures 1989 and reviewed by the Animal Care and Use Review Office (Fort Detrick, MD, USA).","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"All authors and organisations consent to publication.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"There authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Publisher\u2019s Note"}}],"article-number":"2"}}